Transave Secures $12.5 Million Loan
Transave Inc., a Monmouth Junction, N.J.-based developer of inhaled drugs for site-specific treatment of serious lung diseases, has secured a $12.5 million venture loan from CIT Healthcare and Compass Horizon Funding Co. The company has raised nearly $100 million in VC funding from firms like Quaker BioVentures, Bessemer Venture Partners, TVM Capital, Prospect Venture Partners, Fidelity Biosciences, Forbion Capital Partners and Easton Capital.
3 October 2008•5 mins read
